Medicamen Organics Limited (NSE:MEDIORG)

Medicamen Organics Statistics

Total Valuation

NSE:MEDIORG has a market cap or net worth of INR 276.71 million. The enterprise value is 408.35 million.

Market Cap	276.71M
Enterprise Value	408.35M

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:MEDIORG has 11.70 million shares outstanding. The number of shares has increased by 28.87% in one year.

Current Share Class	11.70M
Shares Outstanding	11.70M
Shares Change (YoY)	+28.87%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	70.33%
Owned by Institutions (%)	n/a
Float	3.37M

Valuation Ratios

The trailing PE ratio is 6.16.

PE Ratio	6.16
Forward PE	n/a
PS Ratio	0.70
PB Ratio	0.84
P/TBV Ratio	0.85
P/FCF Ratio	n/a
P/OCF Ratio	70.91
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.95, with an EV/FCF ratio of -15.72.

EV / Earnings	8.93
EV / Sales	1.04
EV / EBITDA	5.95
EV / EBIT	6.30
EV / FCF	-15.72

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.47.

Current Ratio	1.77
Quick Ratio	1.18
Debt / Equity	0.47
Debt / EBITDA	2.28
Debt / FCF	-6.03
Interest Coverage	10.95

Financial Efficiency

Return on equity (ROE) is 15.17% and return on invested capital (ROIC) is 10.83%.

Return on Equity (ROE)	15.17%
Return on Assets (ROA)	7.35%
Return on Invested Capital (ROIC)	10.83%
Return on Capital Employed (ROCE)	18.60%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	3.46M
Profits Per Employee	401,263
Employee Count	114
Asset Turnover	0.72
Inventory Turnover	3.31

Taxes

In the past 12 months, NSE:MEDIORG has paid 14.06 million in taxes.

Income Tax	14.06M
Effective Tax Rate	23.51%

Stock Price Statistics

The stock price has decreased by -51.34% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-51.34%
50-Day Moving Average	26.29
200-Day Moving Average	32.50
Relative Strength Index (RSI)	46.12
Average Volume (20 Days)	10,400

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:MEDIORG had revenue of INR 394.30 million and earned 45.74 million in profits. Earnings per share was 3.84.

Revenue	394.30M
Gross Profit	149.58M
Operating Income	64.81M
Pretax Income	59.81M
Net Income	45.74M
EBITDA	68.60M
EBIT	64.81M
Earnings Per Share (EPS)	3.84

Balance Sheet

The company has 29.05 million in cash and 156.69 million in debt, with a net cash position of -127.64 million or -10.91 per share.

Cash & Cash Equivalents	29.05M
Total Debt	156.69M
Net Cash	-127.64M
Net Cash Per Share	-10.91
Equity (Book Value)	330.18M
Book Value Per Share	27.85
Working Capital	203.26M

Cash Flow

In the last 12 months, operating cash flow was 3.90 million and capital expenditures -29.87 million, giving a free cash flow of -25.97 million.

Operating Cash Flow	3.90M
Capital Expenditures	-29.87M
Free Cash Flow	-25.97M
FCF Per Share	-2.22

Margins

Gross margin is 37.93%, with operating and profit margins of 16.44% and 11.60%.

Gross Margin	37.93%
Operating Margin	16.44%
Pretax Margin	15.17%
Profit Margin	11.60%
EBITDA Margin	17.40%
EBIT Margin	16.44%
FCF Margin	n/a

Dividends & Yields

NSE:MEDIORG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.87%
Shareholder Yield	-28.87%
Earnings Yield	16.53%
FCF Yield	-9.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5